HQ

Abrdn Healthcare Investors

HQHFinancial ServicesNASDAQ

Asset Management

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$99.8M
-46.5% YoY
Net Income
$98.6M
-46.7% YoY

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 72.0, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 84.6, above 70, stock may be overbought
About Abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. At a $1.19B market cap, Abrdn Healthcare Investors ranks as a small-cap company within financial services. The fund invests in public equity markets across the globe.

Key stats
Market Cap$1.19B
P/E (TTM)4.66
EPS$4.48
Beta0.74
52W Change+29.8%
Dividend Yield11.13%
ROE24.2%
Analysis

Abrdn Healthcare Investors carries $0 in total debt, a figure that investors should evaluate relative to the company's earnings power. ROE of 24.2% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from -$192.3M (2022) to $99.8M (2025), reflecting a 152% increase over the period.

Investors considering Abrdn Healthcare Investors should weigh the typical risks associated with HQH's sector, size, and financial profile against their own risk tolerance and investment objectives. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Abrdn Healthcare Investors's trajectory.

Links
More Financial Services stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms